Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | SCN1A | P35498 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.38 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3502282 | 1.00 | KCNN4 (0.38) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL5172183 | 0.90 | KEAP1 (0.42) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL8872460 | 0.90 | KEAP1 (0.38) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL10448783 | 0.90 | KEAP1 (0.42) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL11026818 | 0.90 | KEAP1 (0.38) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL3958141 | 0.90 | KEAP1 (0.42) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL11454390 | 0.90 | KEAP1 (0.38) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL11328095 | 0.84 | KCNN4 (0.38) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL18788591 | 0.82 | CYP2D6 (0.41) | KCNN4TSHRCYP2D6LMNAHRH1 | |
| SCHEMBL10907499 | 0.82 | CYP2D6 (0.41) | KCNN4TSHRCYP2D6LMNAHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1299342-B1 | METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES | SANOL ARZNEI SCHWARZ GMBH (DE) | 2007-05-02 | — | — | EP | claimed |
| US-6809225-B2 | BY HYDROCARBONYLATION/HYDROFORMYLATION WITH SUBSEQUENT REDUCTIVE AMINATION | SCHWARZ PHARMA AG (DE) | 2004-10-26 | — | — | US | claimed |
| US-20040034080-A1 | Method for producing 3,3-diarylpropylamines | UCB PHARMA GMBH (DE) | 2004-02-19 | — | — | US | claimed |
| US-4564711-A | PLATIUM ACETYLACETONATE, 4B METAL HALIDE, BIDENTATE TERTIARY LIGAND | SUN REFINING AND MARKETING COMPANY (US) | 1986-01-14 | — | — | US | claimed |
| US-4542119-A | PLATINUM ACETYLACETON, GROUP 4 HALIDE, ANTIMONY OR ARSENIC OR PHOSPHORUS CONTAINING LIGAND | SUN TECH, INC. (US) | 1985-09-17 | — | — | US | claimed |
| US-4306087-A | RHODIUM-DIPHOSPHINO COMPLEX CATALYST | KURARAY CO., LTD. (JP) | 1981-12-15 | — | — | US | claimed |
| US-4237072-A | HYDROGENATION IN THE PRESENCE OF A RHODIUM CHIRAL PHOSPHINE COMPLEX FORMED IN SITU | RHONE-POULENC INDUSTRIES (FR) | 1980-12-02 | — | — | US | claimed |
| EP-0000315-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE CITRONELLAL | RHONE-POULENC INDUSTRIES (FR) | 1980-09-17 | — | — | EP | claimed |
| US-4201714-A | HYDROFORMYLATION | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | claimed |
| US-4201728-A | RHODIUM METAL COMPLEX CATALYST | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | claimed |
| US-4139565-A | STERIC RELATIONSHIPS | CELANESE CORPORATION (US) | 1979-02-13 | — | — | US | claimed |
| JP-56118034-A | — | — | None | — | — | JP | disclosed |
| EP-3976625-B1 | HIGH LINEAR SELECTIVITY LIGAND FOR ALLYL ALCOHOL HYDROFORMYLATION | LYONDELL CHEMICAL TECH LP (US) | 2023-08-02 | — | — | EP | disclosed |
| US-10807934-B1 | High linear selectivity ligand for allyl alcohol hydroformylation | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2020-10-20 | — | — | US | disclosed |
| US-9950981-B2 | Allyl alcohol hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2018-04-24 | — | — | US | disclosed |
| US-4201714-A | HYDROFORMYLATION | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| US-4201714-A | HYDROFORMYLATION | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| US-4201728-A | RHODIUM METAL COMPLEX CATALYST | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| US-4169861-A | STAVILIZED RHODIUM METAL BIDENTATE LIGAND AND MONODENTATE LIGAND | CELANESE CORPORATION (US) | 1979-10-02 | — | — | US | disclosed |
| US-4139565-A | STERIC RELATIONSHIPS | CELANESE CORPORATION (US) | 1979-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10807934-B1 | High linear selectivity ligand for allyl alcohol hydroformylation | ADH1A, ADH1C, HRH4 | KCNN4 2606/4885TSHR 1975/4885CYP2D6 1536/4885 |
| US-20040034080-A1 | Method for producing 3,3-diarylpropylamines | HNMT, CYP1A1, HRH3 | KCNN4 951/4885TSHR 2088/4885CYP2D6 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.